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The clot-lysing ability of streptokinase (SK) was examined using membrane-bound 
thrombi. Encapsulation of SK in large unilamellar phospholipid vesicles (liposomes) 
resulted in entrapping approximately 30% of its original activity. Measurements of 
streptokinase activity for liposomal-encapsulated streptokinase (LESK) indicated little 
loss of activity or leakage in Tris-buffered saline over a 24-hr period at temperatures 
of 4 and 23°C. However, incubation of free SK and LESK in platelet-poor plasma 
(PPP) at 37°C resulted in a decrease of SK activity. The retention of SK activity in 
LESK was considerably higher than that of unentrapped SK. Clot-dissolving time 
(CDT) was measured by monitoring the pressure drop during slow filtration in plasma 
through membrane-bound thrombi. The results indicated that both LESK and free SK 
were able to activate the fibrinolytic system. Without prior incubation in PPP at 37°C, 
the CDT of a SK and PPP mixture (SK/PPP) was 10.7 ± 1.9 min (n = 12), while that 
of a LESK and PPP mixture (LESK/PPP) was 12.4 ± 1.7 min (n = 12). The CDT-
detected clot-lysing abilities of both SK and LESK were diminished by incubation in 
PPP, but to different extents. After 15- and 30-min incubations, the CDT of SK/PPP 
increased significantly to 15.5 ± 1.5 and 24.1 ± 2.4 min (n = 5, P < 0.05), 
respectively. In contrast, the CDT of LESK/PPP increased to 13.3 ± 0.8 min (n = 5) 
after 15 min of incubation and to 16.0 ± 1.1 min (n = 5, P < 0.05) after a 30-min 
incubation. These results suggest that entrapment of SK in liposomes preserves the 
thrombolytic potential of the plasminogen activator by limiting its exposure to the 
components of the plasma. 
 
